Fuji Pharma Co Ltd (4554) Stock Price & News

4554:TYO

Fuji Pharma Co Ltd

¥1,764.00

-1.40%

(-25.00) 1D

Oct 1, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4554...

Open

¥1,772

High

¥1,772

Low

¥1,749

Mkt. cap

46.82B

Avg. vol.

101.02K

Volume

67.70K

Dividend

2.58%

Quarterly dividend

¥11

Ex-dividend date

Sep 29, 2026

P/E ratio

14.83

52-wk high

¥2,559

52-wk low

¥1,478

EPS

¥119

Shares outstanding

29.92M

No. of employees

Open

¥1,772

High

¥1,772

Low

¥1,749

Mkt. cap

46.82B

Avg. vol.

101.02K

Volume

67.70K

Dividend

2.58%

Quarterly dividend

¥11

Ex-dividend date

Sep 29, 2026

P/E ratio

14.83

52-wk high

¥2,559

52-wk low

¥1,478

EPS

¥119

Shares outstanding

29.92M

No. of employees

Related stocks

4553

Towa Pharmaceutical Co Ltd

¥3,570.00

-1.52%

4887

Sawai Group Holdings Co Ltd

¥1,606.50

-1.80%

4577

Daito Pharmaceutical Co Ltd

¥1,306.00

-1.36%

4539

Nippon Chemiphar Co Ltd

¥1,567.00

+1.10%

News stories

From web sources and news partners

FXStreet

33 minutes ago

S&P 500 (US500) multi-dimensional structural breakdown

Quartz

5 minutes ago

Dow, S&P 500, Nasdaq open higher to start October 2026

TradingView

1 hour ago

S&P 500 equal weight index is on track for seventh straight weekly decline

Currently.com

1 hour ago

Here's What History Says a $1,000 Investment in the Vanguard S&P 500 ETF Could Be Worth in 30 Years

About Fuji Pharma Co Ltd

CEO-

Employees1.76K

FoundedApr 1, 1965

Headquarters-

SectorPharmaceutical industry

Websitefujipharma.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	14.72B	15.90B	13.82B	15.67B
Cost of goods sold	8.71B	9.08B	8.30B	10.33B
Cost of revenue	8.71B	9.08B	8.30B	10.33B
Research and development expenses	3.34B	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-428.00M	4.03B	3.90B	4.34B
Operating expense	4.39B	4.03B	3.90B	4.34B
Total operating expenses	13.10B	13.11B	12.21B	14.67B
Operating income	1.62B	2.79B	1.61B	995.00M
Other non operating income	68.00M	-47.00M	139.00M	222.00M
EBT including unusual items	1.30B	195.00M	489.00M	1.43B
EBT excluding unusual items	1.63B	2.65B	1.68B	1.22B
Income tax expense	133.00M	-129.00M	100.00M	320.00M
Effective tax rate	10.21%	-66.15%	20.45%	22.42%
Other operating expenses	-	-	-	-
Net income	1.17B	324.00M	389.00M	1.11B
Net profit margin	7.95%	2.04%	2.81%	7.07%
Earnings per share	-	-	-	-
Interest and investment income	-	-	1.00M	1.00M
Interest expense	-100.00M	-84.00M	-105.00M	-98.00M
Net interest expenses	-100.00M	-84.00M	-104.00M	-97.00M
Depreciation and amortization charges	1.38B	-	-	-
EBITDA	2.61B	3.78B	2.64B	1.99B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything